N6-Benzoyladenosine

We are N6-Benzoyladenosine CAS:4546-55-8 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:N6-Benzoyladenosine
CAS.NO:4546-55-8
Synonyms:N-[9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-6-yl]benzamide
N-Benzoyladenosine
Molecular Formula:C17H17N5O5
Molecular Weight:371.34700
 
Physical and Chemical Properties:
Density:1.708
Melting point:141-145ºC
 
Specification:
Appearance:White to off-white crystalline powder
Assay(HPLC):≥99.0%
Moisture:≤5.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:N6-Benzoyladenosine is an anti tumor agent.

N6-Benzoyladenosine


Related News: This is called API. A small amount of the active ingredient has an effect, so only a tiny part of the active ingredient is contained in medicine.5-azacitidina CAS:320-67-2 Zhejiang Tianyu Co., Ltd .: It is mainly engaged in the research and development and production of sartan-type APIs and intermediates. It has serialized sartan-type APIs and intermediate products, and has accumulated rich chemical synthesis technology. It has strong technical advantages and Scale advantage.6,12-Dibromochrysene The acquired pharmaceutical intermediates business will be renamed Corden Pharma Switzerland LLC and will operate as part of ICIG’s pharmaceutical business within the Corden Pharma platform. The companies’ goal is to close the transaction during the first quarter of 2011. Financial terms are not disclosed.(2S,3aS,7aS)-Octahydroindole-2-carboxylic acid The acquired pharmaceutical intermediates business will be renamed Corden Pharma Switzerland LLC and will operate as part of ICIG’s pharmaceutical business within the Corden Pharma platform. The companies’ goal is to close the transaction during the first quarter of 2011. Financial terms are not disclosed.The acquired pharmaceutical intermediates business will be renamed Corden Pharma Switzerland LLC and will operate as part of ICIG’s pharmaceutical business within the Corden Pharma platform. The companies’ goal is to close the transaction during the first quarter of 2011. Financial terms are not disclosed.

Related Products
Product Name
3-Bromo-4-fluorophenol View Details
2-Bromo-6-nitrophenol View Details
(R)-3-(3-Fluoro-4-morpholinophenyl)-5-(hydroxymethyl)oxazolidin-2-one View Details
2-Chloro-4-isocyanato-1-methylbenzene manufacturer ethyl 7-chloroheptanoate manufacturer 4-phenylbutan-2-amine manufacturer Dimethoxymethylphenylsilane manufacturer 5-Fluoro-2-methyl-3-nitrobenzoic acid manufacturer